MA16.03 Global RET Registry (GLORY): Activity of RET-Directed Targeted Therapies in RET-Rearranged Lung CancersOliver Gautschi, Alexander Drilon, Julie Milia-Baron et al.|Journal of Thoracic Oncology|2017Cited by 2
KEYNOTE-042 Final Analysis: Pembrolizumab vs Chemotherapy in First-Line PD-L1-Positive Locally Advanced/Metastatic NSCLCKubota Kaoru, G. Lopes, M Kowalski Dariusz et al.|日本臨床腫瘍学会学術集会(CD-ROM)|2019Cited by 0